IndexIQ Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$405K Sell
7,655
-1,925
-20% -$111K 0.01% 609
2021
Q4
$581K Sell
9,580
-620
-6% -$36.8K 0.02% 470
2021
Q3
$572K Buy
10,200
+1,022
+11% +$56.1K 0.02% 467
2021
Q2
$478K Sell
9,178
-7
-0.1% -$336 0.02% 490
2021
Q1
$405K Buy
9,185
+3,475
+61% +$146K 0.01% 580
2020
Q4
$199K Buy
5,710
+589
+12% +$20.9K 0.01% 913
2020
Q3
$187K Buy
5,121
+278
+6% +$10.3K 0.01% 698
2020
Q2
$182K Sell
4,843
-191
-4% -$7.64K 0.01% 674
2020
Q1
$185K Buy
+5,034
New +$196K 0.01% 573

Other funds holding PBH

IndexIQ Advisors's PBH Position: Q1 2022 in Review

IndexIQ Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 20% in Q1 2022, selling an estimated $111K and leaving 7,655 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #609.

IndexIQ Advisors first reported a position in PBH in Q1 2020 and has held it in 9 quarters since. The position peaked at $581K in Q4 2021. 287 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • IndexIQ Advisors held 7,655 shares of Prestige Consumer Healthcare worth $405K as of Q1 2022.
  • IndexIQ Advisors sold 1,925 Prestige Consumer Healthcare shares in Q1 2022, an estimated $111K.
  • Prestige Consumer Healthcare made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #609 holding.
  • IndexIQ Advisors first reported a position in Prestige Consumer Healthcare in Q1 2020 and has held it in 9 quarters since.
  • IndexIQ Advisors's Prestige Consumer Healthcare position peaked at $581K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.